Please login to the form below

Not currently logged in
Email:
Password:

Ethan Knowlden leaves Novartis for Complete Genomics

Joins genome sequencing firm as senior VP, general counsel

Complete Genomics Ethan KnowldenComplete Genomics has appointed Ethan Knowlden as the company's new senior VP, general counsel.

Knowlden joins from Novartis Vaccines and Diagnostics, where he was VP of business development and licensing, and corporate counsel. He spent more than 13 years at Novartis and its predecessor Chiron Corp.

In his new role, he will provide legal advice to Complete Genomics, which is a US subsidiary of the China-based genomics firm BGI-Shenzhen.

Complete Genomics is one of the leading companies working in human genomic sequencing, having sequenced more than 15,000 whole human genomes.

"Whole human genome sequencing will dramatically change the way in which healthcare is practiced in many countries during the next decade and I am delighted to be part of the Complete team at this transformative time," said Knowlden.

19th September 2013

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics